Uses of Botulinum Toxin Injection in Medicine

Dear Colleagues,

In recent decades, we have seen a growing interest in the use of botulinum toxin (mainly type A) in several domains of medicine. From the first utilizations in strabismus and dystonia, the use has widened to spasticity, lower urinary tract dysfunctions, sialorrhea, and headache. Then, to dermatology and cosmesis, pain, achalasia, as well as several gynecological and urological conditions.

The use of botulinum toxin over the years has been so varied that it has led some authors to call it the new panacea. The main reason for this heterogeneous use is mainly due to its principal effect of no cholinergic transmission but also due to its effect on multiple nerve co-transmitters, along with its ease and safety of use.

However, most of the clinical applications of botulinum toxin have a limited level of evidence and are sometimes only limited to case reports.

This Special Issue welcomes original papers or review articles focusing on the different applications that botulinum toxin has in clinical medicine. We seek papers showing the role of botulinum toxin in diagnosis, treatment and/or health maintenance.

We expect to receive papers on traditional and new utilizations of botulinum toxin in cancer medicine, psychiatry, gastrointestinal conditions, musculoskeletal conditions, gynecology and urology. Generalizing, research on all relevant medical conditions in which the use of botulinum toxin has been shown to have potential is welcome.

Dr. Stefano Carda
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.